$MPAD
MICROPAC INDUSTRIES INC Stock $mpad

$mpad Overview Financials Valuation SEC Filings Company Website

2023 Q2 Form 10-Q Financial Statement

#000121465923005207 Filed on April 11, 2023

Income Statement

Concept	2023 Q2	2023 Q1	2022 Q1
Revenue	$7.443M	$6.190M	$6.066M
YoY Change	3.55%	2.04%	49.78%
Cost Of Revenue	$4.583M	$3.939M	$3.276M
YoY Change	7.96%	20.24%	21.78%
Gross Profit	$2.860M	$2.251M	$2.790M
YoY Change	-2.82%	-19.32%	105.15%
Gross Profit Margin	38.43%	36.37%	45.99%
Selling, General & Admin	$2.010M	$1.806M	$1.768M
YoY Change	8.65%	2.15%	27.19%
% of Gross Profit	70.28%	80.23%	63.37%
Research & Development	$625.0K	$652.0K	$464.0K
YoY Change	24.5%	40.52%
% of Gross Profit	21.85%	28.96%	16.63%
Depreciation & Amortization	$273.0K	$103.0K	$98.00K
YoY Change	175.76%	5.1%	-10.91%
% of Gross Profit	9.55%	4.58%	3.51%
Operating Expenses	$2.635M	$2.458M	$2.232M
YoY Change	12.03%	10.13%	28.72%
Operating Profit	$225.0K	-$207.0K	$558.0K
YoY Change	-61.93%	-137.1%	-249.2%
Interest Expense	$3.000K
YoY Change
% of Operating Profit	1.33%
Other Income/Expense, Net	$33.00K	$139.0K	$1.000K
YoY Change	3200.0%	13800.0%	-95.83%
Pretax Income	$258.0K	-$68.00K	$559.0K
YoY Change	-56.42%	-112.16%	-259.71%
Income Tax	$44.00K	-$12.00K	$95.00K
% Of Pretax Income	17.05%		16.99%
Net Earnings	$214.0K	-$56.00K	$464.0K
YoY Change	-56.42%	-112.07%	-254.15%
Net Earnings / Revenue	2.88%	-0.9%	7.65%
Basic Earnings Per Share	$0.08	-$0.02
Diluted Earnings Per Share	$0.08	-$0.02	$180.0K
COMMON SHARES
Basic Shares Outstanding	2.578M shares	2.578M shares
Diluted Shares Outstanding	2.614M shares	2.578M shares

Balance Sheet

Concept	2023 Q2	2023 Q1	2022 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments	$11.66M	$13.24M	$15.90M
YoY Change	-27.21%	-16.72%	19.3%
Cash & Equivalents	$11.66M	$13.24M	$15.90M
Short-Term Investments
Other Short-Term Assets	$367.0K	$594.0K	$280.0K
YoY Change	-12.83%	112.14%	-19.77%
Inventory	$11.95M	$11.34M	$8.853M
Prepaid Expenses
Receivables	$4.120M	$3.532M	$4.276M
Other Receivables	$920.0K	$920.0K	$0.00
Total Short-Term Assets	$29.01M	$29.63M	$29.31M
YoY Change	-1.85%	1.08%	12.27%
LONG-TERM ASSETS
Property, Plant & Equipment	$24.48M	$22.76M	$15.81M
YoY Change	27.6%	44.03%	242.03%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets	$86.00K	$86.00K
YoY Change
Total Long-Term Assets	$24.56M	$22.85M	$15.81M
YoY Change	28.05%	44.57%	240.04%
TOTAL ASSETS
Total Short-Term Assets	$29.01M	$29.63M	$29.31M
Total Long-Term Assets	$24.56M	$22.85M	$15.81M
Total Assets	$53.58M	$52.48M	$45.12M
YoY Change	9.91%	16.32%	46.69%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$838.0K	$1.469M	$1.685M
YoY Change	-47.72%	-12.82%	114.38%
Accrued Expenses	$1.221M	$998.0K	$983.0K
YoY Change	-4.61%	1.53%	13.9%
Deferred Revenue
YoY Change
Short-Term Debt	$0.00	$225.0K	$0.00
YoY Change
Long-Term Debt Due	$282.0K	$225.0K
YoY Change
Total Short-Term Liabilities	$3.110M	$3.363M	$4.245M
YoY Change	-25.1%	-20.78%	138.35%
LONG-TERM LIABILITIES
Long-Term Debt	$15.73M	$14.63M	$8.383M
YoY Change	35.47%	74.57%
Other Long-Term Liabilities			$0.00
YoY Change			-100.0%
Total Long-Term Liabilities	$15.73M	$14.63M	$8.383M
YoY Change	35.47%	74.57%	12411.94%
TOTAL LIABILITIES
Total Short-Term Liabilities	$3.110M	$3.363M	$4.245M
Total Long-Term Liabilities	$15.73M	$14.63M	$8.383M
Total Liabilities	$18.84M	$18.00M	$12.64M
YoY Change	19.4%	42.34%	584.2%
SHAREHOLDERS EQUITY
Retained Earnings	$34.75M	$34.54M
YoY Change
Common Stock	$308.0K	$308.0K
YoY Change
Preferred Stock
YoY Change
Treasury Stock (at cost)	$1.250M	$1.250M
YoY Change
Treasury Stock Shares
Shareholders Equity	$34.74M	$34.48M	$32.47M
YoY Change
Total Liabilities & Shareholders Equity	$53.58M	$52.48M	$45.12M
YoY Change	9.91%	16.32%	46.69%

Cashflow Statement

Concept	2023 Q2	2023 Q1	2022 Q1
OPERATING ACTIVITIES
Net Income	$214.0K	-$56.00K	$464.0K
YoY Change	-56.42%	-112.07%	-254.15%
Depreciation, Depletion And Amortization	$273.0K	$103.0K	$98.00K
YoY Change	175.76%	5.1%	-10.91%
Cash From Operating Activities	-$837.0K	-$1.493M	$1.176M
YoY Change	-286.0%	-226.96%	-432.2%
INVESTING ACTIVITIES
Capital Expenditures	$1.901M	$480.0K	-$5.281M
YoY Change	-153.34%	-109.09%	680.06%
Acquisitions
YoY Change
Other Investing Activities
YoY Change
Cash From Investing Activities	-$1.901M	-$480.0K	-$5.281M
YoY Change	-46.66%	-90.91%	680.06%
FINANCING ACTIVITIES
Cash Dividend Paid		$258.0K	$258.0K
YoY Change		0.0%
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	1.155M	-$158.0K	4.756M
YoY Change	-64.24%	-103.32%	-1943.41%
NET CHANGE
Cash From Operating Activities	-837.0K	-$1.493M	1.176M
Cash From Investing Activities	-1.901M	-$480.0K	-5.281M
Cash From Financing Activities	1.155M	-$158.0K	4.756M
Net Change In Cash	-1.583M	-$2.131M	651.0K
YoY Change	-1464.66%	-427.34%	-150.5%
FREE CASH FLOW
Cash From Operating Activities	-$837.0K	-$1.493M	$1.176M
Capital Expenditures	$1.901M	$480.0K	-$5.281M
Free Cash Flow	-$2.738M	-$1.973M	$6.457M
YoY Change	-168.21%	-130.56%	1899.07%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2023Q1	dei	Entity Central Index Key EntityCentralIndexKey	0000065759
CY2023Q1	dei	Amendment Flag AmendmentFlag	false
CY2023Q1	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2023
CY2023Q1	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	Q1
CY2023Q1	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--11-30
CY2023Q1	dei	Document Type DocumentType	10-Q
CY2023Q1	dei	Document Quarterly Report DocumentQuarterlyReport	true
CY2023Q1	dei	Document Period End Date DocumentPeriodEndDate	2023-02-25
CY2023Q1	dei	Document Transition Report DocumentTransitionReport	false
CY2023Q1	dei	Entity File Number EntityFileNumber	0-5109
CY2023Q1	dei	Entity Registrant Name EntityRegistrantName	MICROPAC INDUSTRIES, INC.
CY2023Q1	dei	Entity Incorporation State Country Code EntityIncorporationStateCountryCode	DE
CY2023Q1	dei	Entity Tax Identification Number EntityTaxIdentificationNumber	75-1225149
CY2023Q1	dei	Entity Address Address Line1 EntityAddressAddressLine1	905 E. Walnut
CY2023Q1	dei	Entity Address City Or Town EntityAddressCityOrTown	Garland
CY2023Q1	dei	Entity Address State Or Province EntityAddressStateOrProvince	TX
CY2023Q1	dei	Entity Address Postal Zip Code EntityAddressPostalZipCode	75040
CY2023Q1	dei	City Area Code CityAreaCode	(972)
CY2023Q1	dei	Local Phone Number LocalPhoneNumber	272-3571
CY2023Q1	dei	Security12b Title Security12bTitle	Common Stock, $0.10 par value per share
CY2023Q1	dei	Trading Symbol TradingSymbol	MPAD
CY2023Q1	dei	Security Exchange Name SecurityExchangeName	NONE
CY2023Q1	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
CY2023Q1	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
CY2023Q1	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	false
CY2023Q1	dei	Entity Small Business EntitySmallBusiness	true
CY2023Q1	dei	Entity Filer Category EntityFilerCategory	Non-accelerated Filer
CY2023Q1	dei	Entity Shell Company EntityShellCompany	false
CY2023Q2	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	2578315	shares
CY2023Q1	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	13244000	usd
CY2022Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	15375000	usd
CY2023Q1	us-gaap	Receivables Net Current ReceivablesNetCurrent	2810000	usd
CY2022Q4	us-gaap	Receivables Net Current ReceivablesNetCurrent	3644000	usd
CY2023Q1	us-gaap	Income Tax Receivable IncomeTaxReceivable	920000	usd
CY2022Q4	us-gaap	Income Tax Receivable IncomeTaxReceivable	920000	usd
CY2023Q1	us-gaap	Contract With Customer Asset Net Current ContractWithCustomerAssetNetCurrent	722000	usd
CY2022Q4	us-gaap	Contract With Customer Asset Net Current ContractWithCustomerAssetNetCurrent	408000	usd
CY2023Q1	us-gaap	Inventory Raw Materials And Supplies InventoryRawMaterialsAndSupplies	7164000	usd
CY2022Q4	us-gaap	Inventory Raw Materials And Supplies InventoryRawMaterialsAndSupplies	6715000	usd
CY2023Q1	us-gaap	Inventory Work In Process And Raw Materials InventoryWorkInProcessAndRawMaterials	4175000	usd
CY2022Q4	us-gaap	Inventory Work In Process And Raw Materials InventoryWorkInProcessAndRawMaterials	3573000	usd
CY2023Q1	us-gaap	Inventory Net InventoryNet	11339000	usd
CY2022Q4	us-gaap	Inventory Net InventoryNet	10288000	usd
CY2023Q1	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	593000	usd
CY2022Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	564000	usd
CY2023Q1	us-gaap	Assets Current AssetsCurrent	29629000	usd
CY2022Q4	us-gaap	Assets Current AssetsCurrent	31199000	usd
CY2023Q1	us-gaap	Land Land	1518000	usd
CY2022Q4	us-gaap	Land Land	1518000	usd
CY2023Q1	us-gaap	Buildings And Improvements Gross BuildingsAndImprovementsGross	498000	usd
CY2022Q4	us-gaap	Buildings And Improvements Gross BuildingsAndImprovementsGross	498000	usd
CY2023Q1	us-gaap	Inventory Buildings And Improvements InventoryBuildingsAndImprovements	1126000	usd
CY2022Q4	us-gaap	Inventory Buildings And Improvements InventoryBuildingsAndImprovements	1126000	usd
CY2023Q1	us-gaap	Furniture And Fixtures Gross FurnitureAndFixturesGross	1183000	usd
CY2022Q4	us-gaap	Furniture And Fixtures Gross FurnitureAndFixturesGross	1036000	usd
CY2023Q1	us-gaap	Flight Equipment Net FlightEquipmentNet	19575000	usd
CY2022Q4	us-gaap	Flight Equipment Net FlightEquipmentNet	19415000	usd
CY2023Q1	us-gaap	Machinery And Equipment Gross MachineryAndEquipmentGross	10024000	usd
CY2022Q4	us-gaap	Machinery And Equipment Gross MachineryAndEquipmentGross	9952000	usd
CY2023Q1	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	33924000	usd
CY2022Q4	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	33545000	usd
CY2023Q1	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	11160000	usd
CY2022Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	11082000	usd
CY2023Q1	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	22764000	usd
CY2022Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	22463000	usd
CY2022Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	14000	usd
CY2023Q1	us-gaap	Deferred Income Tax Assets Net DeferredIncomeTaxAssetsNet	86000	usd
CY2022Q4	us-gaap	Deferred Income Tax Assets Net DeferredIncomeTaxAssetsNet	86000	usd
CY2023Q1	us-gaap	Assets Assets	52479000	usd
CY2022Q4	us-gaap	Assets Assets	53762000	usd
CY2023Q1	us-gaap	Accounts Payable Current AccountsPayableCurrent	1469000	usd
CY2022Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	1173000	usd
CY2023Q1	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	842000	usd
CY2022Q4	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	1086000	usd
CY2023Q1	us-gaap	Deferred Revenue DeferredRevenue	646000	usd
CY2022Q4	us-gaap	Deferred Revenue DeferredRevenue	1192000	usd
CY2023Q1	MPAD	Property Taxes PropertyTaxes	131000	usd
CY2022Q4	MPAD	Property Taxes PropertyTaxes	560000	usd
CY2023Q1	us-gaap	Taxes Payable Current TaxesPayableCurrent	25000	usd
CY2022Q4	us-gaap	Taxes Payable Current TaxesPayableCurrent	149000	usd
CY2023Q1	us-gaap	Convertible Debt Current ConvertibleDebtCurrent	225000	usd
CY2022Q4	us-gaap	Convertible Debt Current ConvertibleDebtCurrent	224000	usd
CY2023Q1	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	25000	usd
CY2022Q4	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	47000	usd
CY2023Q1	us-gaap	Liabilities Current LiabilitiesCurrent	3363000	usd
CY2022Q4	us-gaap	Liabilities Current LiabilitiesCurrent	4431000	usd
CY2023Q1	us-gaap	Long Term Debt Noncurrent LongTermDebtNoncurrent	14634000	usd
CY2022Q4	us-gaap	Long Term Debt Noncurrent LongTermDebtNoncurrent	14535000	usd
CY2023Q1	us-gaap	Liabilities Liabilities	17997000	usd
CY2022Q4	us-gaap	Liabilities Liabilities	18966000	usd
CY2023Q1	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.10
CY2022Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.10
CY2023Q1	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	10000000	shares
CY2022Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	10000000	shares
CY2023Q1	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	3078315	shares
CY2022Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	3078315	shares
CY2023Q1	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	2578315	shares
CY2022Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	2578315	shares
CY2023Q1	us-gaap	Common Stock Value CommonStockValue	308000	usd
CY2022Q4	us-gaap	Common Stock Value CommonStockValue	308000	usd
CY2023Q1	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	885000	usd
CY2022Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	885000	usd
CY2023Q1	MPAD	Treasury Stocks Shares TreasuryStocksShares	500000	shares
CY2022Q4	MPAD	Treasury Stocks Shares TreasuryStocksShares	500000	shares
CY2023Q1	us-gaap	Treasury Stock Value TreasuryStockValue	1250000	usd
CY2022Q4	us-gaap	Treasury Stock Value TreasuryStockValue	1250000	usd
CY2023Q1	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	34539000	usd
CY2022Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	34853000	usd
CY2023Q1	us-gaap	Stockholders Equity StockholdersEquity	34482000	usd
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	34796000	usd
CY2023Q1	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	52479000	usd
CY2022Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	53762000	usd
CY2023Q1	us-gaap	Revenues Revenues	6190000	usd
CY2022Q1	us-gaap	Revenues Revenues	6066000	usd
CY2023Q1	us-gaap	Cost Of Revenue CostOfRevenue	3939000	usd
CY2022Q1	us-gaap	Cost Of Revenue CostOfRevenue	3276000	usd
CY2023Q1	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	652000	usd
CY2022Q1	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	464000	usd
CY2023Q1	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	1806000	usd
CY2022Q1	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	1768000	usd
CY2023Q1	us-gaap	Costs And Expenses CostsAndExpenses	6397000	usd
CY2022Q1	us-gaap	Costs And Expenses CostsAndExpenses	5508000	usd
CY2023Q1	us-gaap	Operating Income Loss OperatingIncomeLoss	-207000	usd
CY2022Q1	us-gaap	Operating Income Loss OperatingIncomeLoss	558000	usd
CY2023Q1	us-gaap	Other Income OtherIncome	139000	usd
CY2022Q1	us-gaap	Other Income OtherIncome	1000	usd
CY2023Q1	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-68000	usd
CY2022Q1	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	559000	usd
CY2023Q1	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-12000	usd
CY2022Q1	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	95000	usd
CY2023Q1	us-gaap	Net Income Loss NetIncomeLoss	-56000	usd
CY2022Q1	us-gaap	Net Income Loss NetIncomeLoss	464000	usd
CY2023Q1	MPAD	Net Income Per Share Basic And Diluted NetIncomePerShareBasicAndDiluted	-0.02
CY2022Q1	MPAD	Net Income Per Share Basic And Diluted NetIncomePerShareBasicAndDiluted	0.18
CY2023Q1	us-gaap	Common Stock Dividends Per Share Cash Paid CommonStockDividendsPerShareCashPaid	0.10
CY2022Q1	us-gaap	Common Stock Dividends Per Share Cash Paid CommonStockDividendsPerShareCashPaid	0.10
CY2023Q1	MPAD	Weighted Average Of Shares Basic And Diluted WeightedAverageOfSharesBasicAndDiluted	2578315	shares
CY2022Q1	MPAD	Weighted Average Of Shares Basic And Diluted WeightedAverageOfSharesBasicAndDiluted	2578315	shares
CY2023Q1	us-gaap	Net Income Loss NetIncomeLoss	-56000	usd
CY2022Q1	us-gaap	Net Income Loss NetIncomeLoss	464000	usd
CY2023Q1	us-gaap	Depreciation Depreciation	103000	usd
CY2022Q1	us-gaap	Depreciation Depreciation	98000	usd
CY2023Q1	us-gaap	Operating Lease Right Of Use Asset Amortization Expense OperatingLeaseRightOfUseAssetAmortizationExpense	14000	usd
CY2022Q1	us-gaap	Operating Lease Right Of Use Asset Amortization Expense OperatingLeaseRightOfUseAssetAmortizationExpense	13000	usd
CY2023Q1	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	-834000	usd
CY2022Q1	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	-1490000	usd
CY2023Q1	us-gaap	Increase Decrease In Contract With Customer Asset IncreaseDecreaseInContractWithCustomerAsset	314000	usd
CY2022Q1	us-gaap	Increase Decrease In Contract With Customer Asset IncreaseDecreaseInContractWithCustomerAsset	189000	usd
CY2023Q1	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	1051000	usd
CY2022Q1	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	168000	usd
CY2023Q1	us-gaap	Increase Decrease In Prepaid Expenses Other IncreaseDecreaseInPrepaidExpensesOther	29000	usd
CY2022Q1	us-gaap	Increase Decrease In Prepaid Expenses Other IncreaseDecreaseInPrepaidExpensesOther	-61000	usd
CY2023Q1	us-gaap	Increase Decrease In Deferred Revenue IncreaseDecreaseInDeferredRevenue	-546000	usd
CY2022Q1	us-gaap	Increase Decrease In Deferred Revenue IncreaseDecreaseInDeferredRevenue	181000	usd
CY2023Q1	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	372000	usd
CY2022Q1	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	-8000	usd
CY2023Q1	MPAD	Accrued Compensation AccruedCompensation	244000	usd
CY2022Q1	MPAD	Accrued Compensation AccruedCompensation	451000	usd
CY2023Q1	us-gaap	Increase Decrease In Accrued Income Taxes Payable IncreaseDecreaseInAccruedIncomeTaxesPayable	-124000	usd
CY2022Q1	us-gaap	Increase Decrease In Accrued Income Taxes Payable IncreaseDecreaseInAccruedIncomeTaxesPayable	-42000	usd
CY2023Q1	us-gaap	Increase Decrease In Operating Lease Liability IncreaseDecreaseInOperatingLeaseLiability	-14000	usd
CY2022Q1	us-gaap	Increase Decrease In Operating Lease Liability IncreaseDecreaseInOperatingLeaseLiability	-13000	usd
CY2023Q1	us-gaap	Increase Decrease In Other Accrued Liabilities IncreaseDecreaseInOtherAccruedLiabilities	-438000	usd
CY2022Q1	us-gaap	Increase Decrease In Other Accrued Liabilities IncreaseDecreaseInOtherAccruedLiabilities	-260000	usd
CY2023Q1	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-1493000	usd
CY2022Q1	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	1176000	usd
CY2023Q1	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	480000	usd
CY2022Q1	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	5281000	usd
CY2023Q1	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-480000	usd
CY2022Q1	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-5281000	usd
CY2023Q1	us-gaap	Payments Of Dividends PaymentsOfDividends	258000	usd
CY2022Q1	us-gaap	Payments Of Dividends PaymentsOfDividends	258000	usd
CY2023Q1	us-gaap	Proceeds From Issuance Of Long Term Debt ProceedsFromIssuanceOfLongTermDebt	100000	usd
CY2022Q1	us-gaap	Proceeds From Issuance Of Long Term Debt ProceedsFromIssuanceOfLongTermDebt	5014000	usd
CY2023Q1	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-158000	usd
CY2022Q1	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	4756000	usd
CY2023Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect	-2131000	usd
CY2022Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect	651000	usd
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	15375000	usd
CY2021Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	15252000	usd
CY2023Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	13244000	usd
CY2022Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	15903000	usd
CY2023Q1	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet	118000	usd
CY2022Q1	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet	137000	usd
CY2023Q1	MPAD	Accrued Additions Property Plant Equipment AccruedAdditionsPropertyPlantEquipment	75000	usd
CY2022Q1	MPAD	Accrued Additions Property Plant Equipment AccruedAdditionsPropertyPlantEquipment	-269000	usd
CY2021Q4	us-gaap	Stockholders Equity StockholdersEquity	32267000	usd
CY2022Q1	us-gaap	Dividends Dividends	258000	usd
CY2022Q1	us-gaap	Net Income Loss NetIncomeLoss	464000	usd
CY2022Q1	us-gaap	Stockholders Equity StockholdersEquity	32473000	usd
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	34796000	usd
CY2023Q1	us-gaap	Dividends Dividends	258000	usd
CY2023Q1	us-gaap	Net Income Loss NetIncomeLoss	-56000	usd
CY2023Q1	us-gaap	Stockholders Equity StockholdersEquity	34482000	usd
CY2023Q1	us-gaap	Revenues Revenues	6190000	usd
CY2022Q1	us-gaap	Revenues Revenues	6066000	usd
CY2023Q1	us-gaap	Revenues Revenues	6190000	usd
CY2022Q1	us-gaap	Revenues Revenues	6066000	usd
CY2023Q1	MPAD	Domestic Direct DomesticDirect	3618000	usd
CY2023Q1	MPAD	Domestic Distrbution DomesticDistrbution	2296000	usd
CY2023Q1	MPAD	International Distribution InternationalDistribution	276000	usd
CY2023Q1	us-gaap	Revenues Revenues	6190000	usd
CY2022Q1	MPAD	Domestic Direct DomesticDirect	3852000	usd
CY2022Q1	MPAD	Domestic Distrbution DomesticDistrbution	2078000	usd
CY2022Q1	MPAD	International Distribution InternationalDistribution	136000	usd
CY2022Q1	us-gaap	Revenues Revenues	6066000	usd
CY2023Q1	us-gaap	Debt Instrument Interest Rate During Period DebtInstrumentInterestRateDuringPeriod	0.0325	pure
CY2023Q1	us-gaap	Receivables Net Current ReceivablesNetCurrent	2810000	usd
CY2022Q4	us-gaap	Receivables Net Current ReceivablesNetCurrent	3644000	usd
CY2021Q4	us-gaap	Receivables Net Current ReceivablesNetCurrent	4974000	usd
CY2023Q1	us-gaap	Contract With Customer Asset Net Current ContractWithCustomerAssetNetCurrent	722000	usd
CY2022Q4	us-gaap	Contract With Customer Asset Net Current ContractWithCustomerAssetNetCurrent	408000	usd
CY2021Q4	us-gaap	Contract With Customer Asset Net Current ContractWithCustomerAssetNetCurrent	603000	usd
CY2023Q1	us-gaap	Deferred Revenue DeferredRevenue	646000	usd
CY2022Q4	us-gaap	Deferred Revenue DeferredRevenue	1192000	usd
CY2021Q4	us-gaap	Deferred Revenue DeferredRevenue	1258000	usd
CY2023Q1	MPAD	Deferred Revenue Recognized DeferredRevenueRecognized	546000	usd
CY2023Q1	us-gaap	Operating Lease Expense OperatingLeaseExpense	14000	usd
CY2022Q1	us-gaap	Operating Lease Expense OperatingLeaseExpense	13000	usd
CY2023Q1	us-gaap	Liability For Uncertain Tax Positions Current LiabilityForUncertainTaxPositionsCurrent	0	usd
CY2022Q4	us-gaap	Liability For Uncertain Tax Positions Current LiabilityForUncertainTaxPositionsCurrent	0	usd
CY2023Q1	MPAD	Dilutive Potential Coommon Stock Instruments DilutivePotentialCoommonStockInstruments	0	shares
CY2022Q1	MPAD	Dilutive Potential Coommon Stock Instruments DilutivePotentialCoommonStockInstruments	0	shares
CY2023Q1	us-gaap	Use Of Estimates UseOfEstimates	<p id="xdx_844_eus-gaap--UseOfEstimates_zTLSQMHEjMG8" style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span id="xdx_862_zMCTtABrnlm5">Use of Estimates</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimates.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p>
CY2023Q1	MPAD	Fair Value Financial Assets Liabilities Recurring Basis FairValueFinancialAssetsLiabilitiesRecurringBasis	0	usd
CY2022Q4	MPAD	Fair Value Financial Assets Liabilities Recurring Basis FairValueFinancialAssetsLiabilitiesRecurringBasis	0	usd
CY2023Q1	us-gaap	Notes Payable NotesPayable	15010000	usd
CY2023Q1	us-gaap	Notes Payable NotesPayable	15010000	usd
CY2023Q1	us-gaap	Unamortized Debt Issuance Expense UnamortizedDebtIssuanceExpense	151000	usd
CY2023Q1	MPAD	Net Debt NetDebt	14859000	usd
CY2023Q1	us-gaap	Debt Current DebtCurrent	225000	usd
CY2023Q1	us-gaap	Long Term Debt Noncurrent LongTermDebtNoncurrent	14634000	usd
CY2023Q1	us-gaap	Long Term Debt Maturities Repayments Of Principal In Next Twelve Months LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths	225000	usd
CY2023Q1	us-gaap	Long Term Debt Maturities Repayments Of Principal In Year Two LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo	396000	usd
CY2023Q1	us-gaap	Long Term Debt Maturities Repayments Of Principal In Year Three LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree	409000	usd
CY2023Q1	us-gaap	Long Term Debt Maturities Repayments Of Principal In Year Four LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour	423000	usd
CY2023Q1	us-gaap	Long Term Debt Maturities Repayments Of Principal In Year Five LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive	438000	usd
CY2023Q1	us-gaap	Long Term Debt Maturities Repayments Of Principal After Year Five LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFive	13119000	usd
CY2023Q1	us-gaap	Long Term Debt LongTermDebt	15010000	usd
CY2023Q1	MPAD	Dilutive Potential Coommon Stock Instruments DilutivePotentialCoommonStockInstruments	0	shares
CY2022Q1	MPAD	Dilutive Potential Coommon Stock Instruments DilutivePotentialCoommonStockInstruments	0	shares
CY2023Q1	us-gaap	Dividends Payable Date Declared Day Month And Year DividendsPayableDateDeclaredDayMonthAndYear	2022-12-07
CY2023Q1	us-gaap	Common Stock Dividends Per Share Cash Paid CommonStockDividendsPerShareCashPaid	0.10
CY2023Q1	us-gaap	Dividends Payable Date Of Record Day Month And Year DividendsPayableDateOfRecordDayMonthAndYear	2023-01-11
CY2023Q1	us-gaap	Dividend Payable Date To Be Paid Day Month And Year DividendPayableDateToBePaidDayMonthAndYear	2023-02-10
CY2022Q1	us-gaap	Dividends Payable Date Declared Day Month And Year DividendsPayableDateDeclaredDayMonthAndYear	2021-12-07
CY2022Q1	us-gaap	Common Stock Dividends Per Share Cash Paid CommonStockDividendsPerShareCashPaid	0.10
CY2022Q1	us-gaap	Dividends Payable Date Of Record Day Month And Year DividendsPayableDateOfRecordDayMonthAndYear	2022-01-11
CY2022Q1	us-gaap	Dividend Payable Date To Be Paid Day Month And Year DividendPayableDateToBePaidDayMonthAndYear	2022-02-10

Files In Submission

Name	View Source	Status
0001214659-23-005207-index-headers.html	Edgar Link	pending
0001214659-23-005207-index.html	Edgar Link	pending
0001214659-23-005207.txt	Edgar Link	pending
0001214659-23-005207-xbrl.zip	Edgar Link	pending
ex31_1.htm	Edgar Link	pending
ex31_2.htm	Edgar Link	pending
ex32_1.htm	Edgar Link	pending
ex32_2.htm	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
j41023010q.htm	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
mpad-20230225.xsd	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending
mpad-20230225_lab.xml	Edgar Link	unprocessable
FilingSummary.xml	Edgar Link	unprocessable
mpad-20230225_cal.xml	Edgar Link	unprocessable
mpad-20230225_def.xml	Edgar Link	unprocessable
mpad-20230225_pre.xml	Edgar Link	unprocessable
j41023010q_htm.xml	Edgar Link	completed

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$MPAD
MICROPAC INDUSTRIES INC Stock $mpad

2023 Q2 Form 10-Q Financial Statement

#000121465923005207 Filed on April 11, 2023

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$MPAD MICROPAC INDUSTRIES INC Stock $mpad

2023 Q2 Form 10-Q Financial Statement

#000121465923005207 Filed on April 11, 2023

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$MPAD
MICROPAC INDUSTRIES INC Stock $mpad